IMB-202

N/A

Report date: 2025/07/04 16:55:25

Base Information

Drug NameIMB-202
Drug Alias NameIMB-202
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionT lymphocytes stimulantsAntibody-dependent cell-mediated cytotoxicity (ADCC) effects
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIMBiologics Corp
China Registration ClassN/A

Develop Information

Active CompaniesIMBiologics Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A